Dabur receives US FDA warning letter for Silvassa plant; says issue limited to private label exports

The company added that domestic products are not covered under the US FDA action and that the Silvassa facility continues to operate for the domestic market. “Domestic products are not covered and not impacted by this order. The aforesaid plant continues to be operational for the domestic market,” the company said.

Leave a Reply

Your email address will not be published. Required fields are marked *